Clinical Trials Directory

Trials / Completed

CompletedNCT03715036

Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits

Point of Care Ultrasound Screening for Abnormal Fetal Growth During Routine Antenatal Visits: a Randomized Controlled Trial. MUNN (More Ultrasounds New gaiNs) Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
177 (actual)
Sponsor
The University of Texas Medical Branch, Galveston · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Abdominal circumference (AC) in the fetus is the single most useful indicator of fetal growth abnormalities. Measurement of AC as well as DVP do not require extensive training. Our objective is to evaluate if introduction of bedside ultrasound during routine antenatal visits to evaluate fetal AC and amniotic fluid DVP would decrease the false positive rates of fundal height measurement in diagnosing intrauterine growth abnormalities.

Detailed description

The prior studies of routine ultrasound in low risk patients focused on the usual ultrasound evaluation which involves the use of advanced equipment and providers, including trained sonographers and physicians to perform and review the ultrasound, as well as a full examination with multiple fetal measurements and images. A number of recent analyses show that measurement of the abdominal circumference (AC) in the fetus is the single most useful indicator of fetal growth abnormalities. Measurement of AC as well as DVP do not require extensive training, long time to acquire, or expensive ultrasound machines. They can be easily performed in the office by providers who are specifically trained in obtaining these 2 measurements. Therefore, we intended to evaluate if introduction of bedside ultrasound during routine antenatal visits (point of care ultrasound or POC-US) to evaluate fetal AC and amniotic fluid DVP would decrease the false positive rates of fundal height measurement in diagnosing intrauterine growth abnormalities, and would improve the diagnosis of amniotic fluid volume and fetal growth deviations.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPoint-of-care USThe intervention includes reassuring the AC and DVP

Timeline

Start date
2019-04-29
Primary completion
2020-03-30
Completion
2020-03-30
First posted
2018-10-22
Last updated
2021-09-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03715036. Inclusion in this directory is not an endorsement.